Trial · NCT04535544
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-blind (Day 1 up to Week 52) | STARTED | Part 1: JNJ-73763989 + Nucleos(t)Ide Analog (NA) | 17 | |
| Double-blind (Day 1 up to Week 52) | STARTED | Part 1: Placebo + NA | 5 | |
| Double-blind (Day 1 up to Week 52) | STARTED | Part 2: JNJ-73763989 + NA | 24 | |
| Double-blind (Day 1 up to Week 52) | STARTED | Part 2: Placebo + NA | 6 | |
| Double-blind (Day 1 up to Week 52) | COMPLETED | Part 1: JNJ-73763989 + Nucleos(t)Ide Analog (NA) | 16 | |
| Double-blind (Day 1 up to Week 52) | COMPLETED | Part 1: Placebo + NA | 5 | |
| Double-blind (Day 1 up to Week 52) | COMPLETED | Part 2: JNJ-73763989 + NA | 20 | |
| Double-blind (Day 1 up to Week 52) | COMPLETED | Part 2: Placebo + NA | 5 | |
| Double-blind (Day 1 up to Week 52) | NOT COMPLETED | Part 1: JNJ-73763989 + Nucleos(t)Ide Analog (NA) | 1 | |
| Double-blind (Day 1 up to Week 52) | NOT COMPLETED | Part 1: Placebo + NA | 0 | |
| Double-blind (Day 1 up to Week 52) | NOT COMPLETED | Part 2: JNJ-73763989 + NA | 4 | |
| Double-blind (Day 1 up to Week 52) | NOT COMPLETED | Part 2: Placebo + NA | 1 | |
| Open-label (Week 52 up to Week 148) | STARTED | Part 1: JNJ-73763989 + Nucleos(t)Ide Analog (NA) | 5 | |
| Open-label (Week 52 up to Week 148) | STARTED | Part 1: Placebo + NA | 4 | |
| Open-label (Week 52 up to Week 148) | STARTED | Part 2: JNJ-73763989 + NA | 14 | |
| Open-label (Week 52 up to Week 148) | STARTED | Part 2: Placebo + NA | 5 | |
| Open-label (Week 52 up to Week 148) | COMPLETED | Part 1: JNJ-73763989 + Nucleos(t)Ide Analog (NA) | 5 | |
| Open-label (Week 52 up to Week 148) | COMPLETED | Part 1: Placebo + NA | 2 | |
| Open-label (Week 52 up to Week 148) | COMPLETED | Part 2: JNJ-73763989 + NA | 0 | |
| Open-label (Week 52 up to Week 148) | COMPLETED | Part 2: Placebo + NA | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04535544/flow